Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

ABOSABOS
20 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in ACUMEN PHARMACEUTICALS INC

NORTHERN TRUST CORP holds 360,744 shares of ABOS (ACUMEN PHARMACEUTICALS INC), worth $963,187 as of 2026-Q2. The position was increased (+379.6% shares). ABOS represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$963,187

Current Shares

360,744

Total Value Change

-$335,813

Total Shares Change

+273,343

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
360,744
+379.6%
$963,1870.0%$2.67
40
2026-Q1
Unchanged
75,212
0.0%
$177,5000.0%$3.31
0
2025-Q4
Increased
75,212
+15.8%
$158,6970.0%$2.00
18
2025-Q3
Decreased
64,954
-0.3%
$111,0710.0%$1.58
0
2025-Q2
Decreased
65,162
-77.5%
$75,5880.0%$1.12
0
2025-Q1
Decreased
289,836
-5.8%
$318,8200.0%$1.19
0
2024-Q4
Decreased
307,615
-0.4%
$529,0980.0%$1.75
0
2024-Q3
Increased
308,850
+340.7%
$765,9480.0%$2.48
40
2024-Q2
Increased
70,088
+23.4%
$169,6130.0%$2.42
19
2024-Q1
Increased
56,773
+0.2%
$229,9310.0%$4.05
16
2023-Q4
Increased
56,678
+0.9%
$217,6430.0%$3.84
16
2023-Q3
Increased
56,190
+75.1%
$233,1890.0%$4.15
24
2023-Q2
Decreased
32,094
-0.2%
$154,3720.0%$4.81
0
2023-Q1
Decreased
32,158
-6.5%
$130,5620.0%$4.08
0
2022-Q4
Increased
34,384
+33.6%
$185,6740.0%$5.40
20
2022-Q3
Increased
25,742
+19.5%
$259,0000.0%$10.48
27
2022-Q2
Decreased
21,546
-90.0%
$101,0000.0%$4.88
0
2022-Q1
Increased
216,168
+127.6%
$845,0000.0%$3.97
40
2021-Q4
Increased
94,984
+8.7%
$642,0000.0%$6.90
27
2021-Q3
New
87,401
-
$1.3M0.0%$14.85
35

Other major holders of ABOS: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used